Article
Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost.
Hormones & cancer - 1 Aug 2012
Lindsey Susan C, Kunii Ilda S, Germano-Neto Fausto, Sittoni Misaki Y, Camacho Cléber P, Valente Flávia O F, Yang Ji H, Signorini Priscila S, Delcelo Rosana, Cerutti Janete M, Maciel Rui M B, Dias-da-Silva Magnus R
Abstract excerpt
RET sequencing has become an important tool in medullary thyroid cancer (MTC) evaluation and should be performed even in the absence of family history of MTC. The most commonly studied exons in index cases are 8, 10, 11, and 13-16. To address the ATA guidelines regarding the sequencing of the entire coding region of RET, we selected 50 patients with sporadic MTC (sMTC) without mutations in the hot spot regions of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
